<DOC>
	<DOCNO>NCT00531622</DOCNO>
	<brief_summary>The main purpose study evaluate efficacy saredutant 100mg daily combination escitalopram 10mg daily compare saredutant placebo combination escitalopram 10mg daily patient major depressive disorder . This study also include double-placebo group ( saredutant placebo combination escitalopram placebo ) .</brief_summary>
	<brief_title>An Eight-week Study Saredutant Escitalopram Combination Treatment Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Outpatients recurrent Major Depressive Disorder Symptoms current depressive episode less 30 day 2 year Mild depression , measure standard clinical research scale Significant suicide risk Lack sexual activity ( include masturbation ) Other psychiatric condition would obscure result study History failure respond antidepressant treatment Pregnancy breastfeed The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>Major Depressive Episode</keyword>
	<keyword>Antidepressant</keyword>
</DOC>